HK1254209A1 - 头孢烯化合物、其制备和用途 - Google Patents
头孢烯化合物、其制备和用途 Download PDFInfo
- Publication number
- HK1254209A1 HK1254209A1 HK18113349.1A HK18113349A HK1254209A1 HK 1254209 A1 HK1254209 A1 HK 1254209A1 HK 18113349 A HK18113349 A HK 18113349A HK 1254209 A1 HK1254209 A1 HK 1254209A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- unsubstituted
- substituted
- attached
- cephem compounds
- spacer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/48—Methylene radicals, substituted by hetero rings
- C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562265625P | 2015-12-10 | 2015-12-10 | |
| US62/265,625 | 2015-12-10 | ||
| PCT/CA2016/051428 WO2017096472A1 (en) | 2015-12-10 | 2016-12-05 | Cephem compounds, their production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1254209A1 true HK1254209A1 (zh) | 2019-07-12 |
Family
ID=59012429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18113349.1A HK1254209A1 (zh) | 2015-12-10 | 2016-12-05 | 头孢烯化合物、其制备和用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9751894B2 (https=) |
| EP (1) | EP3386977A4 (https=) |
| JP (1) | JP6967000B2 (https=) |
| KR (2) | KR102135230B1 (https=) |
| CN (1) | CN108463461B (https=) |
| AU (1) | AU2016367284C1 (https=) |
| BR (1) | BR112018009725A8 (https=) |
| CA (1) | CA3005779C (https=) |
| EA (1) | EA039648B1 (https=) |
| HK (1) | HK1254209A1 (https=) |
| IL (1) | IL259234B (https=) |
| WO (1) | WO2017096472A1 (https=) |
| ZA (1) | ZA201802654B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108463461B (zh) | 2015-12-10 | 2021-11-19 | 奈加-Rgm制药有限公司 | 头孢烯化合物、其制备和用途 |
| KR20200091395A (ko) * | 2017-09-27 | 2020-07-30 | 페도라 파마슈티칼스 인코포레이티드 | 디아자비시클로옥탄 유도체의 결정형 및 그의 제조 방법 |
| TWI795549B (zh) * | 2018-04-06 | 2023-03-11 | 日商富士軟片股份有限公司 | 新穎青黴烷衍生物或其鹽、醫藥組成物及其應用 |
| KR102484880B1 (ko) | 2018-06-08 | 2023-01-05 | 엘지디스플레이 주식회사 | 신축 가능한 표시장치, 패널 구동회로 및 구동방법 |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| SG11202101255UA (en) | 2018-08-09 | 2021-03-30 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| WO2020263975A1 (en) | 2019-06-24 | 2020-12-30 | Diverse Biotech, Inc. | Beta-lactam-cannabinoid conjugate molecules |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3118732A1 (de) | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
| US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
| IL77458A (en) * | 1985-01-14 | 1990-07-26 | Eisai Co Ltd | Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor |
| ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| US4777128A (en) | 1986-05-27 | 1988-10-11 | Ethigen Corporation | Fluorescence immunoassay involving energy transfer between two fluorophores |
| GB8805642D0 (en) | 1988-03-09 | 1988-04-07 | Fujisawa Pharmaceutical Co | New cephem compounds & processes for preparation thereof |
| US5173485A (en) * | 1988-03-09 | 1992-12-22 | Fujisawa Pharmaceutical Company, Ltd. | Cephem compounds |
| US5215982A (en) | 1989-11-10 | 1993-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| CA2216259A1 (en) | 1996-09-25 | 1998-03-25 | Eisai Chemical Co., Ltd. | Production process of cephem compound |
| TW526202B (en) * | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
| JP2003026679A (ja) * | 2001-07-10 | 2003-01-29 | Banyu Pharmaceut Co Ltd | 新規カルバペネム誘導体 |
| TW200305422A (en) * | 2002-03-18 | 2003-11-01 | Shionogi & Co | Broad spectrum cefem compounds |
| KR101023035B1 (ko) | 2002-10-30 | 2011-03-24 | 와쿠나가 세이야쿠 가부시키 가이샤 | 세펨 화합물 |
| EP1994035A1 (en) | 2006-03-16 | 2008-11-26 | Astellas Pharma Inc. | Cephem compounds and use as antimicrobial agents |
| CN101343281A (zh) * | 2007-04-20 | 2009-01-14 | 山东轩竹医药科技有限公司 | 新型脒基吡啶基头孢菌素类化合物 |
| CN102203100B (zh) * | 2008-10-31 | 2014-08-27 | 盐野义制药株式会社 | 具有邻苯二酚基团的头孢菌素 |
| KR20130018845A (ko) | 2010-04-05 | 2013-02-25 | 시오노기세야쿠 가부시키가이샤 | 카테콜기를 갖는 세펨 화합물 |
| WO2011125966A1 (ja) | 2010-04-05 | 2011-10-13 | 塩野義製薬株式会社 | 擬似カテコール基を有するセフェム化合物 |
| JP5852562B2 (ja) | 2010-04-28 | 2016-02-03 | 塩野義製薬株式会社 | 新規なセフェム誘導体 |
| ES2653837T3 (es) * | 2010-06-18 | 2018-02-09 | Fob Synthesis, Inc. | Antibacterianos carbapenem con actividad gramo-negativa |
| KR101719556B1 (ko) | 2011-03-30 | 2017-03-24 | 주식회사 레고켐 바이오사이언스 | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 |
| EP2703406A4 (en) | 2011-04-28 | 2015-08-05 | Shionogi & Co | NOVEL CEPHEM COMPOUND HAVING THE CATÉCHOL STRUCTURE OR A STRUCTURE CLOSE TO CATÉCHOL |
| JP2013012630A (ja) | 2011-06-30 | 2013-01-17 | Toyota Industries Corp | 熱電変換モジュール |
| TWI547496B (zh) | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
| JPWO2013051597A1 (ja) | 2011-10-04 | 2015-03-30 | 塩野義製薬株式会社 | カテコール基を有するセフェム誘導体 |
| US8809314B1 (en) * | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| UY35103A (es) | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
| WO2014087165A1 (en) | 2012-12-06 | 2014-06-12 | University Of Bath | Tankyrase inhibitors |
| US20150344502A1 (en) * | 2012-12-26 | 2015-12-03 | Shionogi & Co., Ltd. | Cephem compound |
| CN108463461B (zh) | 2015-12-10 | 2021-11-19 | 奈加-Rgm制药有限公司 | 头孢烯化合物、其制备和用途 |
-
2016
- 2016-12-05 CN CN201680072172.7A patent/CN108463461B/zh not_active Expired - Fee Related
- 2016-12-05 CA CA3005779A patent/CA3005779C/en active Active
- 2016-12-05 KR KR1020197010752A patent/KR102135230B1/ko not_active Expired - Fee Related
- 2016-12-05 HK HK18113349.1A patent/HK1254209A1/zh unknown
- 2016-12-05 JP JP2018529261A patent/JP6967000B2/ja active Active
- 2016-12-05 BR BR112018009725A patent/BR112018009725A8/pt not_active IP Right Cessation
- 2016-12-05 EA EA201891381A patent/EA039648B1/ru unknown
- 2016-12-05 WO PCT/CA2016/051428 patent/WO2017096472A1/en not_active Ceased
- 2016-12-05 AU AU2016367284A patent/AU2016367284C1/en not_active Ceased
- 2016-12-05 US US15/369,181 patent/US9751894B2/en not_active Ceased
- 2016-12-05 EP EP16871861.7A patent/EP3386977A4/en active Pending
- 2016-12-05 KR KR1020187015784A patent/KR20180066264A/ko not_active Ceased
-
2018
- 2018-04-20 ZA ZA2018/02654A patent/ZA201802654B/en unknown
- 2018-05-09 IL IL259234A patent/IL259234B/en active IP Right Grant
- 2018-12-19 US US16/225,892 patent/USRE48097E1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190042752A (ko) | 2019-04-24 |
| CN108463461B (zh) | 2021-11-19 |
| JP2018536678A (ja) | 2018-12-13 |
| AU2016367284A1 (en) | 2018-05-10 |
| EP3386977A1 (en) | 2018-10-17 |
| BR112018009725A2 (en) | 2018-11-06 |
| CA3005779C (en) | 2020-04-07 |
| JP6967000B2 (ja) | 2021-11-17 |
| CN108463461A (zh) | 2018-08-28 |
| EP3386977A4 (en) | 2019-05-22 |
| BR112018009725A8 (pt) | 2019-02-26 |
| CA3005779A1 (en) | 2017-06-15 |
| IL259234B (en) | 2018-12-31 |
| EA201891381A1 (ru) | 2019-01-31 |
| US9751894B2 (en) | 2017-09-05 |
| AU2016367284B2 (en) | 2018-05-17 |
| KR102135230B1 (ko) | 2020-07-17 |
| EA039648B1 (ru) | 2022-02-21 |
| ZA201802654B (en) | 2019-07-31 |
| USRE48097E1 (en) | 2020-07-14 |
| AU2016367284C1 (en) | 2018-09-20 |
| KR20180066264A (ko) | 2018-06-18 |
| US20170166587A1 (en) | 2017-06-15 |
| WO2017096472A1 (en) | 2017-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254209A1 (zh) | 头孢烯化合物、其制备和用途 | |
| PH12017502090A1 (en) | Heterocyclic amides as kinase inhibitors | |
| PH12018500342A1 (en) | Heterocyclic amides as kinase inhibitors | |
| PH12016502358B1 (en) | Novel pyrrolidine compound and application as melanocortin receptor agonist | |
| IL311677B1 (en) | History of bicyclic heterocyclyls as IRAK4 inhibitors | |
| EP3008044A4 (en) | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors | |
| NZ727601A (en) | Dihydropyrimido fused ring derivative as hbv inhibitor | |
| MX2016011992A (es) | Derivados de piperidina-diona. | |
| PH12016502147A1 (en) | Substituted 4-phenylpiperidines, their preparation and use | |
| MX2018008095A (es) | Compuestos heterociclicos triciclicos condensados como inhibidores de integrasa del vih. | |
| EP3303341A4 (en) | Fused tricyclic heterocyclic compounds useful for treating hiv infection | |
| MA40170A (fr) | Dérivés hétérocycliques de morphinan et leur utilisation | |
| MX364479B (es) | Nuevos derivados de indol y de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MX2015017156A (es) | Inhibidores de bace. | |
| MX2016012451A (es) | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina. | |
| PH12017501280A1 (en) | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators | |
| MY162886A (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
| PT3733665T (pt) | Compostos contendo unidade de 2-oxo-1,3,4-tiadiazinan-3-ilo com atividade agonista do recetor ep4 | |
| IL270789A (en) | Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| ZA201800269B (en) | Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound | |
| MX2013010962A (es) | Nuevos derivados de furanona. | |
| MX2016006807A (es) | Derivados de imidazol. | |
| HK1254355A1 (zh) | Bace1抑制剂2-氨基-7a-苯基-3，4，4a，5，7，7a-六氢呋喃并[3，4-b]吡啶 | |
| HK40049724A (en) | Fused ring compound having urea structure |